| Mr Eric R Lamb, MD | |
|
3950 17th St, Suite A, Baker City, OR 97814-1300 | |
| (541) 523-1001 | |
| Not Available |
| Full Name | Mr Eric R Lamb |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 3950 17th St, Baker City, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750379244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD23679 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Island city, OR | Home health agency |
| Heart N Home Hospice & Palliative Care | Fruitland, ID | Hospice |
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St. Alphonsus Medical Center - Baker City | Baker city, OR | Hospital |
| Grande Ronde Hospital | La grande, OR | Hospital |
| St Anthony Hospital | Pendleton, OR | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
For the past seven years, the U.S. Food and Drug Administration has reported on cases of a type of lymphoma associated with breast implants.
StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.
› Verified 7 days ago
| Entity Name | Saint Alphonsus Medical Center Baker City, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881726206 PECOS PAC ID: 4981732518 Enrollment ID: O20100618000209 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
For the past seven years, the U.S. Food and Drug Administration has reported on cases of a type of lymphoma associated with breast implants.
StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.
› Verified 7 days ago
| Entity Name | Saint Alphonsus Medical Center- Ontario Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093034159 PECOS PAC ID: 1456488899 Enrollment ID: O20100713000593 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
For the past seven years, the U.S. Food and Drug Administration has reported on cases of a type of lymphoma associated with breast implants.
StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.
› Verified 7 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20120420000013 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
For the past seven years, the U.S. Food and Drug Administration has reported on cases of a type of lymphoma associated with breast implants.
StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Eric R Lamb, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | Mr Eric R Lamb, MD 3950 17th St, Suite A, Baker City, OR 97814-1300 Ph: (541) 523-1001 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
For the past seven years, the U.S. Food and Drug Administration has reported on cases of a type of lymphoma associated with breast implants.
StockPreacher.com announces an investment report featuring ARCA biopharma Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.
› Verified 7 days ago
Dr. Lisa Christina Lanning, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3325 Pocahontas Rd, Baker City, OR 97814 Phone: 541-524-8000 Fax: 541-524-7955 | |
Dean Nathanial Defrees, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3950 17th St Ste A, Baker City, OR 97814 Phone: 541-523-1001 Fax: 541-523-1152 | |
Kaare E Tingelstad, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3325 Pocahontas, Baker City, OR 97814 Phone: 541-523-8111 Fax: 541-523-1738 | |
Dr. Robert Menzie Mckim, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3175 Pocahontas Rd, Baker City, OR 97814 Phone: 541-523-4415 Fax: 541-523-2399 | |
Mr. J Daniel Smithson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3950 17th St, Suite A, Baker City, OR 97814 Phone: 541-523-1001 Fax: 541-523-1152 | |
Neil J Carroll, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3950 17th St, Baker City, OR 97814 Phone: 541-523-1001 Fax: 541-523-1152 | |
Josh Sirucek, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3325 Pocahontas Rd, Baker City, OR 97814 Phone: 514-523-1797 Fax: 514-523-1799 |